
Valarie E. Bertoglio
Examiner (ID: 294, Phone: (571)272-0725 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 1278 |
| Issued Applications | 615 |
| Pending Applications | 184 |
| Abandoned Applications | 505 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15282103
[patent_doc_number] => 10513709
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-24
[patent_title] => Somatic cell nuclear transfer methods
[patent_app_type] => utility
[patent_app_number] => 15/895976
[patent_app_country] => US
[patent_app_date] => 2018-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 20742
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15895976
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/895976 | Somatic cell nuclear transfer methods | Feb 12, 2018 | Issued |
Array
(
[id] => 18329461
[patent_doc_number] => 11634690
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Agent for accelerating growth of pluripotent stem cells
[patent_app_type] => utility
[patent_app_number] => 16/481760
[patent_app_country] => US
[patent_app_date] => 2018-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 4919
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16481760
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/481760 | Agent for accelerating growth of pluripotent stem cells | Jan 30, 2018 | Issued |
Array
(
[id] => 13841137
[patent_doc_number] => 20190024053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => Chondrocyte Precursors Derived From Human Embryonic Stem Cells
[patent_app_type] => utility
[patent_app_number] => 15/877301
[patent_app_country] => US
[patent_app_date] => 2018-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15877301
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/877301 | Chondrocyte Precursors Derived From Human Embryonic Stem Cells | Jan 21, 2018 | Abandoned |
Array
(
[id] => 16361415
[patent_doc_number] => 20200318166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => Multiplexed Screening
[patent_app_type] => utility
[patent_app_number] => 16/478448
[patent_app_country] => US
[patent_app_date] => 2018-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16478448
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/478448 | Multiplexed Screening | Jan 17, 2018 | Abandoned |
Array
(
[id] => 12904936
[patent_doc_number] => 20180193487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => GENE AND CELL THERAPY USING CELL FUSION TECHNOLOGY
[patent_app_type] => utility
[patent_app_number] => 15/873488
[patent_app_country] => US
[patent_app_date] => 2018-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15873488
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/873488 | Gene and cell therapy using cell fusion technology | Jan 16, 2018 | Issued |
Array
(
[id] => 13616905
[patent_doc_number] => 20180360004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => METHOD FOR PRODUCING CHIMERIC ANIMAL
[patent_app_type] => utility
[patent_app_number] => 15/873482
[patent_app_country] => US
[patent_app_date] => 2018-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16549
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15873482
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/873482 | Method for producing chimeric animal | Jan 16, 2018 | Issued |
Array
(
[id] => 16137715
[patent_doc_number] => 10701907
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Method for producing YY super-male and XY physiological female common carps
[patent_app_type] => utility
[patent_app_number] => 15/870334
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2689
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 305
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15870334
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/870334 | Method for producing YY super-male and XY physiological female common carps | Jan 11, 2018 | Issued |
Array
(
[id] => 15039185
[patent_doc_number] => 20190330597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => COMPOSITION FOR CULTURE OF PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 16/476796
[patent_app_country] => US
[patent_app_date] => 2018-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12543
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16476796
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/476796 | COMPOSITION FOR CULTURE OF PLURIPOTENT STEM CELLS | Jan 10, 2018 | Abandoned |
Array
(
[id] => 15866973
[patent_doc_number] => 20200140890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => PYRALID MOTH EGG, PRODUCING METHOD THEREOF, AND METHOD FOR PRODUCING RECOMBINANT PROTEIN BY USING PYRALID MOTH EGG
[patent_app_type] => utility
[patent_app_number] => 16/619137
[patent_app_country] => US
[patent_app_date] => 2017-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5021
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16619137
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/619137 | PYRALID MOTH EGG, PRODUCING METHOD THEREOF, AND METHOD FOR PRODUCING RECOMBINANT PROTEIN BY USING PYRALID MOTH EGG | Dec 18, 2017 | Abandoned |
Array
(
[id] => 16642350
[patent_doc_number] => 10920191
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Methods of screening embryonic progenitor cell lines
[patent_app_type] => utility
[patent_app_number] => 15/846181
[patent_app_country] => US
[patent_app_date] => 2017-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 47768
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15846181
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/846181 | Methods of screening embryonic progenitor cell lines | Dec 17, 2017 | Issued |
Array
(
[id] => 18013497
[patent_doc_number] => 11505781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Compositions and methods for maturation of oocytes in vitro
[patent_app_type] => utility
[patent_app_number] => 16/467911
[patent_app_country] => US
[patent_app_date] => 2017-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17234
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467911
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/467911 | Compositions and methods for maturation of oocytes in vitro | Dec 7, 2017 | Issued |
Array
(
[id] => 17958716
[patent_doc_number] => 20220339296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS, TYPE I
[patent_app_type] => utility
[patent_app_number] => 16/466130
[patent_app_country] => US
[patent_app_date] => 2017-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22610
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16466130
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/466130 | GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS, TYPE I | Dec 5, 2017 | Abandoned |
Array
(
[id] => 12585600
[patent_doc_number] => 20180087029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => Methods of Culturing Retinal Pigmented Epithelium Cells, Including Xeno-Free Production, RPE Enrichment, and Cryopreservation
[patent_app_type] => utility
[patent_app_number] => 15/816912
[patent_app_country] => US
[patent_app_date] => 2017-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13221
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15816912
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/816912 | Methods of culturing retinal pigmented epithelium cells, including Xeno-free production, RPE enrichment, and cryopreservation | Nov 16, 2017 | Issued |
Array
(
[id] => 15175107
[patent_doc_number] => 20190358145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => USE OF CELL MEMBRANE-BOUND SIGNALING FACTORS
[patent_app_type] => utility
[patent_app_number] => 16/461752
[patent_app_country] => US
[patent_app_date] => 2017-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10059
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461752
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/461752 | USE OF CELL MEMBRANE-BOUND SIGNALING FACTORS | Nov 15, 2017 | Abandoned |
Array
(
[id] => 16680724
[patent_doc_number] => 10940180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Method for identifying, expanding, and removing adult stem cells and cancer stem cells
[patent_app_type] => utility
[patent_app_number] => 15/813863
[patent_app_country] => US
[patent_app_date] => 2017-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 27
[patent_no_of_words] => 30140
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15813863
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/813863 | Method for identifying, expanding, and removing adult stem cells and cancer stem cells | Nov 14, 2017 | Issued |
Array
(
[id] => 14836903
[patent_doc_number] => 20190276852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => METHOD FOR DELIVERING EXOGENOUS MITOCHONDRIA INTO CELLS
[patent_app_type] => utility
[patent_app_number] => 16/348549
[patent_app_country] => US
[patent_app_date] => 2017-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6842
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348549
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/348549 | METHOD FOR DELIVERING EXOGENOUS MITOCHONDRIA INTO CELLS | Nov 13, 2017 | Abandoned |
Array
(
[id] => 14246575
[patent_doc_number] => 10273479
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-30
[patent_title] => b-actin promoters and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/809415
[patent_app_country] => US
[patent_app_date] => 2017-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 14
[patent_no_of_words] => 11331
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15809415
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/809415 | b-actin promoters and uses thereof | Nov 9, 2017 | Issued |
Array
(
[id] => 19106018
[patent_doc_number] => 11959103
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-16
[patent_title] => Method for inducing pluripotent stem cells to differentiate into somatic cells
[patent_app_type] => utility
[patent_app_number] => 16/348944
[patent_app_country] => US
[patent_app_date] => 2017-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 16
[patent_no_of_words] => 11941
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348944
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/348944 | Method for inducing pluripotent stem cells to differentiate into somatic cells | Nov 8, 2017 | Issued |
Array
(
[id] => 18545484
[patent_doc_number] => 11718825
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Generation of human oocytes
[patent_app_type] => utility
[patent_app_number] => 16/347949
[patent_app_country] => US
[patent_app_date] => 2017-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 64
[patent_no_of_words] => 14388
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16347949
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/347949 | Generation of human oocytes | Nov 7, 2017 | Issued |
Array
(
[id] => 18428911
[patent_doc_number] => 11674122
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-13
[patent_title] => Method for inducing differentiated cell into Mesenchymal Stem Cell, and combinations of regulatory targets thereof
[patent_app_type] => utility
[patent_app_number] => 16/347627
[patent_app_country] => US
[patent_app_date] => 2017-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 7926
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16347627
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/347627 | Method for inducing differentiated cell into Mesenchymal Stem Cell, and combinations of regulatory targets thereof | Nov 5, 2017 | Issued |